These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial. Hsu C; Kuo SH; Hu FC; Cheng AL; Shih JY; Yu CJ; Lin CC; Huang TC; Yang PC; Yang CH Lung Cancer; 2008 Dec; 62(3):334-43. PubMed ID: 18450322 [TBL] [Abstract][Full Text] [Related]
24. Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial. Usami N; Yokoi K; Hasegawa Y; Taniguchi H; Shindo J; Yamamoto M; Suzuki R; Imaizumi K; Kondo M; Shimokata K; Int J Clin Oncol; 2010 Dec; 15(6):583-7. PubMed ID: 20714770 [TBL] [Abstract][Full Text] [Related]
25. Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study. Soto Parra H; Cavina R; Latteri F; Sala A; Dambrosio M; Antonelli G; Morenghi E; Alloisio M; Ravasi G; Santoro A Ann Oncol; 2002 Jul; 13(7):1080-6. PubMed ID: 12176787 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer. Wu YL; Lu S; Cheng Y; Zhou C; Wang M; Qin S; Lu Y; Zhang Y; Zhu Y; Song X; Wang X; Barraclough H; Zhang X; Chi H; Orlando M Lung Cancer; 2014 Sep; 85(3):401-7. PubMed ID: 25082564 [TBL] [Abstract][Full Text] [Related]
27. Gemcitabine-cisplatin given on day 1 every 3 weeks in advanced non-small cell lung cancer. Karacetin D; Incekara O J BUON; 2006; 11(2):181-4. PubMed ID: 17318968 [TBL] [Abstract][Full Text] [Related]
28. Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer. Yan D; Wei P; An G; Chen W J Cardiothorac Surg; 2013 Jun; 8():149. PubMed ID: 23759026 [TBL] [Abstract][Full Text] [Related]
29. Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: a phase I-II study. Southern Italy Cooperative Oncology Group. Frasci G; Panza N; Comella P; Nicolella GP; Natale M; Manzione L; Bilancia D; Cioffi R; Maiorino L; De Cataldis G; Belli M; Micillo E; Mascia V; Massidda B; Lorusso V; De Lena M; Carpagnano F; Contu A; Pusceddu G; Comella G J Clin Oncol; 1999 Aug; 17(8):2316-25. PubMed ID: 10561293 [TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemotherapy with gemcitabine and cisplatin in stage IIIA/B non-small cell lung cancer. Van Kooten M; Rosenberg M; Orlando M; Morero J; Vilanova M; Rojas O; Vicente H; Bagnes C; Silva C; Chacón RD Invest New Drugs; 2002 Nov; 20(4):439-46. PubMed ID: 12448663 [TBL] [Abstract][Full Text] [Related]
31. Phase II trial of weekly gemcitabine and split-dose cisplatin for advanced non-small-cell lung cancer. Hiramatsu A; Iwasaki Y; Koyama Y; Tamiya N; Hosogi S; Nakanishi M; Kohno Y; Ueda M; Arimoto T; Marunaka Y Jpn J Clin Oncol; 2009 Dec; 39(12):779-83. PubMed ID: 19783552 [TBL] [Abstract][Full Text] [Related]
32. Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naïve non-small cell lung cancer. Keskin S; Tas F; Ekenel M; Kilic L; Sen F; Yildiz I; Karabulut S; Ciftci R; Vatansever S Tumori; 2013; 99(4):463-8. PubMed ID: 24326833 [TBL] [Abstract][Full Text] [Related]
33. [Phase II trial of prolonged infusion of low-dose gemcitabine in advanced non-small cell lung cancer treatment]. Xiong JP; Zhang L; Zhong LX; Qiu F; Guo YL; Lian HY; Luo H Ai Zheng; 2006 Aug; 25(8):995-8. PubMed ID: 16965681 [TBL] [Abstract][Full Text] [Related]
34. Second-line chemotherapy with paclitaxel, cisplatin and gemcitabine in pre-treated sensitive cisplatin-based patients with advanced non-small cell lung cancer. Rosati G; Rossi A; Nicolella G; Panza N Anticancer Res; 2000; 20(3B):2229-33. PubMed ID: 10928183 [TBL] [Abstract][Full Text] [Related]
35. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial. Thatcher N; Hirsch FR; Luft AV; Szczesna A; Ciuleanu TE; Dediu M; Ramlau R; Galiulin RK; Bálint B; Losonczy G; Kazarnowicz A; Park K; Schumann C; Reck M; Depenbrock H; Nanda S; Kruljac-Letunic A; Kurek R; Paz-Ares L; Socinski MA; Lancet Oncol; 2015 Jul; 16(7):763-74. PubMed ID: 26045340 [TBL] [Abstract][Full Text] [Related]
36. Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma. Shin SJ; Kim H; Baek JH; Ahn JJ; Jegal Y; Seo KW; Park CR; Shin JK; Jung JP; Kim JW; Cha HJ; Kwon WJ; Jeong AK; Noh YJ; Park JH; Min YJ Lung Cancer; 2008 Apr; 60(1):83-91. PubMed ID: 18006180 [TBL] [Abstract][Full Text] [Related]
37. Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma: a Phase II multicenter study. De Marinis F; Nelli F; Migliorino MR; Martelli O; Cortesi E; Treggiari S; Portalone L; Crispino C; Brancaccio L; Gridelli C Cancer; 2003 Oct; 98(8):1707-15. PubMed ID: 14534888 [TBL] [Abstract][Full Text] [Related]
38. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901. Garrido P; González-Larriba JL; Insa A; Provencio M; Torres A; Isla D; Sanchez JM; Cardenal F; Domine M; Barcelo JR; Tarrazona V; Varela A; Aguilo R; Astudillo J; Muguruza I; Artal A; Hernando-Trancho F; Massuti B; Sanchez-Ronco M; Rosell R J Clin Oncol; 2007 Oct; 25(30):4736-42. PubMed ID: 17947721 [TBL] [Abstract][Full Text] [Related]